BTIG Reiterates Buy Rating on Mereo BipPharma Group (MREO)

March 26, 2025 11:56 AM EDT Send to a Friend
BTIG analyst Julian Harrison reiterated a Buy rating and $6.00 price target on Mereo BipPharma Group (NASDAQ: MREO).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login